Sort
53,477 grants matching “addiction”
Improving Retention across the OUD Service Cascade upon Re-entry from Jail using Recovery Management Checkups
$1,860,072Christy K Scott · Chestnut Health Systems, Inc. · UG1 · FY2021 · DA
Associative learning, decision-making, and addiction
$1,859,252Geoffrey Schoenbaum · National Institute On Drug Abuse · ZIA · FY2023 · DA
Signaling to and from the Synapse
$1,857,751Richard L Huganir · Johns Hopkins University · P50 · FY2010 · MH
Yale/NIDA Neuroproteomics Center
$1,857,701Kenneth Robert Williams · Yale University · P30 · FY2025 · DA
Stanford CAM Center for Chronic Back Pain
$1,857,665Sean C Mackey · Stanford University · P01 · FY2015 · AT
Northeast Node of the National Drug Abuse Clinical Trials Network
$1,857,620Lisa A Marsch · Dartmouth College · UG1 · FY2021 · DA
MARVEL: A Multidisciplinary Assessment of Risks from Vaping during Early Life
$1,856,948Erin L Sutfin · Wake Forest University Health Sciences · P01 · FY2023 · CA
Neurobiology Of Relapse To Opiate and Psychostimulant Drugs
$1,855,483Yavin Shaham · National Institute On Drug Abuse · ZIA · FY2019 · DA
AMPA Antagonism: A Novel Pharmacology for Launching Recovery from Opioid Addiction
$1,854,492Robert Andrew Chambers · Indiana University Indianapolis · UG3 · FY2020 · DA
Northeast Node of the National Drug Abuse Clinical Trials Network
$1,854,476Lisa A Marsch · Dartmouth College · UG1 · FY2023 · DA
Alcohol Pharmacokinetics and Pharmacodynamics in Humans
$1,854,006Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
Center for chronic pain and drug abuse
$1,853,750Apkar Vania Apkarian · Northwestern University At Chicago · P50 · FY2018 · DA
Functional and Structural Brain Circuits Underlying Smoking
$1,852,171Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2018 · DA
BIOLOGY OF NEUROENDOCRINE PEPTIDES
$1,850,318Salk Institute For Biological Studies · P01 · FY2001 · DK
Plasticity at the Excitatory Synapse
$1,849,317Richard L Huganir · Johns Hopkins University · P50 · FY2017 · MH
Functional Genomics and HCV-Associated Liver Disease
$1,848,035Michael G Katze · University Of Washington · P30 · FY2010 · DA
Discovery of an Orexin-1 receptor antagonist for treatment of cocaine addiction and dependence
$1,847,427Fiona Marshall · Heptares Therapeutics, Ltd · R01 · FY2015 · DA
Tobacco Dependence & Risk Factors for Treatment Failure
$1,847,061Stephanie S O'Malley · Yale University · P50 · FY2006 · AA
Improving Retention across the OUD Service Cascade upon Re-entry from Jail using Recovery Management Checkups
$1,846,711Christy K Scott · Chestnut Health Systems, Inc. · UG1 · FY2019 · DA
Penn PET Addiction Center of Excellence (Penn PACE)
$1,846,343Robert H Mach · University Of Pennsylvania · P30 · FY2021 · DA
Development of Adrb3 Antagonists for the Treatment of Pain
$1,846,202Andrea G Nackley · Duke University · R61 · FY2023 · NS
Pharmacogenetics of Nicotine Addiction and Treatment
$1,846,187Neal L Benowitz · University Of California, San Francisco · U01 · FY2008 · DA
Molecular and Cellular Pathogenesis in Alcoholism
$1,845,183Fulton T Crews · Univ Of North Carolina Chapel Hill · P60 · FY2015 · AA
CURE CTU
$1,845,017Stephen A Spector · University Of California, San Diego · UM1 · FY2025 · AI
A Methamphetamine Conjugate Vaccine: From Manufacturing to IND
$1,843,400Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2015 · DA